synergy for proteus meningitis
Posted inDiseases S

Synergy for Proteus Meningitis

Proteus species, particularly Proteus mirabilis and Proteus vulgaris, are Gram-negative bacilli commonly associated with urinary tract infections. However, their involvement in central nervous system (CNS)…
synergy for neonatal meningitis
Posted inDiseases S

Synergy for Neonatal Meningitis

Neonatal meningitis remains a critical condition with significant morbidity and mortality worldwide. Effective treatment depends not only on early diagnosis and appropriate antimicrobial therapy but…
synergy for listeria monocytogenes septicemia
Posted inDiseases S

Synergy for Listeria monocytogenes Septicemia

Listeria monocytogenes, a facultative intracellular Gram-positive bacillus, poses significant treatment challenges, particularly in septicemic forms of infection affecting immunocompromised individuals, neonates, pregnant women, and the…
synergy for klebsiella meningitis
Posted inDiseases S

Synergy for Klebsiella Meningitis

Klebsiella pneumoniae meningitis presents a critical challenge, particularly when the strain exhibits multidrug resistance (MDR). Synergistic antibiotic therapy is pivotal for maximizing clinical efficacy and…
synergy for escherichia coli meningitis
Posted inCondition S

Synergy for Escherichia coli Meningitis

Escherichia coli (E. coli), a Gram-negative bacillus, is one of the most common etiologic agents of bacterial meningitis, especially in neonates and immunocompromised individuals. Among…